We are live on ! Find out more
Thrivent Financial for Lutherans

Thrivent Financial for Lutherans Portfolio holdings

AUM $59.5B
1-Year Est. Return 35.96%
This Fund
S&P 500
This Quarter Est. Return
+20.5%
1 Year Est. Return
+35.96%
3 Year Est. Return
+101.94%
5 Year Est. Return
+123.95%
10 Year Est. Return
+534.51%
AUM
$59.5B
AUM Growth
+$7.02B
Cap. Flow
-$1.02B
Cap. Flow %
-1.72%
Top 10 Hldgs %
19.06%
Holding
2,699
New
171
Increased
908
Reduced
1,321
Closed
110

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$376M
2
TSM icon
TSMC
TSM
+$201M
3
CAT icon
Caterpillar
CAT
+$179M
4
SHOP icon
Shopify
SHOP
+$134M
5
IBB icon
iShares Biotechnology ETF
IBB
+$97M

Sector Composition

Rank Sector Weight
1 Technology 21.75%
2 Miscellaneous 20.09%
3 Industrials 12.03%
4 Financials 10.62%
5 Healthcare 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSE
2501
Wise Group
WSE
$12.2B
$134K ﹤0.01%
+11,172
New +$133K
NMZ icon
2502
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.07B
$132K ﹤0.01%
12,530
TE
2503
T1 Energy
TE
$1.45B
$115K ﹤0.01%
+12,110
New +$86.1K
PSKY
2504
Paramount Skydance Corp
PSKY
$11.5B
$115K ﹤0.01%
11,625
-139
-1% -$1.46K
JOBY icon
2505
Joby Aviation
JOBY
$6.35B
$111K ﹤0.01%
12,612
+990
+9% +$9.57K
LYG icon
2506
Lloyds Banking Group
LYG
$85.7B
$109K ﹤0.01%
18,733
+178
+1% +$965
NRDS icon
2507
NerdWallet
NRDS
$599M
$101K ﹤0.01%
+10,915
New +$102K
TSHA icon
2508
Taysha Gene Therapies
TSHA
$1.74B
$98K ﹤0.01%
+14,520
New +$85.9K
FATE icon
2509
Fate Therapeutics
FATE
$292M
$93K ﹤0.01%
34,105
GENI icon
2510
Genius Sports
GENI
$1.88B
$83K ﹤0.01%
13,467
+529
+4% +$2.74K
NIO icon
2511
NIO
NIO
$9.27B
$75K ﹤0.01%
14,820
MMT
2512
Aberdeen Multi-Market Income Fund
MMT
$244M
$71K ﹤0.01%
+16,200
New +$73.3K
HDSN
2513
Hudson Technologies
HDSN
$224M
$64K ﹤0.01%
11,129
MYGN icon
2514
Myriad Genetics
MYGN
$305M
$64K ﹤0.01%
11,214
ABAT icon
2515
American Battery Technology Co
ABAT
$366M
$55K ﹤0.01%
19,554
-669
-3% -$2.14K
ICL icon
2516
ICL Group
ICL
$7.59B
$55K ﹤0.01%
11,046
-419
-4% -$2.38K
WIT icon
2517
Wipro
WIT
$16.6B
$39K ﹤0.01%
17,490
-153,803
-90% -$327K
LCTX icon
2518
Lineage Cell Therapeutics
LCTX
$260M
$13K ﹤0.01%
10,000
ARAY icon
2519
Accuray
ARAY
$29.9M
$9K ﹤0.01%
34,080
AGI icon
2520
Alamos Gold
AGI
$15.5B
-17,548
Closed -$780K
AIV
2521
Aimco
AIV
$357M
-14,138
Closed -$58K
AL
2522
DELISTED
Air Lease Corp
AL
-70,492
Closed -$4.58M
ALIT icon
2523
Alight
ALIT
$335M
-29,936
Closed -$348K
ALNY icon
2524
Alnylam Pharmaceuticals
ALNY
$34.5B
-20,470
Closed -$6.77M
AMAL icon
2525
Amalgamated Financial
AMAL
$1.43B
-66,580
Closed -$2.59M

Similar funds

Thrivent Financial for Lutherans's Q2 2026 Portfolio in Review

As of Q2 2026, Thrivent Financial for Lutherans held 2,699 positions worth $59.5B, up 13% from $52.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Thrivent Financial for Lutherans's Q2 2026 filing shows 171 new, 908 increased, 1,321 reduced and 110 closed positions. Its largest new stake was Thrivent International Large Cap ETF: 33,204,703 shares worth $842M. The largest sale was ExxonMobil, an estimated $376M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Miscellaneous and Industrials.

  • Thrivent Financial for Lutherans's largest Q2 2026 buy was Thrivent International Large Cap ETF: 33,204,703 shares worth $842M.
  • Thrivent Financial for Lutherans added most to Applied Materials in Q2 2026, an estimated $162M increase.
  • Thrivent Financial for Lutherans's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $376M.
  • Thrivent Financial for Lutherans fully exited ICF International in Q2 2026, selling an estimated $43.1M.
  • Thrivent Financial for Lutherans's ten largest holdings make up 19% of its $59.5B portfolio in Q2 2026.
  • Thrivent Financial for Lutherans opened 171 new positions and closed 110 in Q2 2026.
  • Thrivent Financial for Lutherans's portfolio value rose 13% quarter-over-quarter to $59.5B.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.